(redirected from Multiple-Dose Vials)
Category filter:
MDVMaldives (ISO Country code)
MDVMaster Diver (US Navy designation)
MDVMarek's Disease Virus
MDVMini Digital Video
MDVMcMurdo Dry Valleys (snow-free valleys; Antarctica)
MDVMultivariate Data Visualization
MDVMedical, Dental, Vision (healthcare benefits)
MDVMobile Digital Video (various organizations)
MDVMarine Dealer Visitor
MDVMaster Donor Virus
MDVMomentum Density Vector (electromagnetics)
MDVMultiple-Dose Vials
MDVMagic Deck Vortex (gaming)
MDVMesenteric Drained Viscera
MDVMulti-Drive Version
MDVMaterial Obligation Validation
MDVMedizinischer Dienst des Verkehrswesens (DDR)
MDVMarine Digital Voice
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(8,9) In the current study 165 of 205 vials (80.49%) were SDVs that were used as multiple-dose vials. This finding is more than reported percentage of 50% in the literature.
Bacterial contamination of multiple-dose vials: a prevalence study.
Baxter recalled many lots and doses and temporarily stopped manufacturing multiple-dose vials of injectable heparin.
Today, few vaccines are drawn from multiple-dose vials, because most manufacturers have shifted production to single-use syringes to further reduce the risk of bacterial contamination.
Specialist pharmaceutical company Mylan Inc (Nasdaq:MYL) stated on Tuesday that it has introduced Mesna Injection, 100 mg/mL, packaged in 1,000 mg/10mL multiple-dose vials, in the market with immediate effect.
says the Food and Drug Administration has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.
Lack of availability of Td in single-dose syringes, resulting in provider purchase of multiple-dose vials, was cited as a contributing factor to medication error in one cluster.
Packaged in 100-mg/16.7-mL and 300-mg/50-mL multiple-dose vials, the product is an alternative to Bristol-Myers Squibb Co.'s Taxol.
typically, injections included doses of atropine, dexamethasone, and vitamin B12 drawn from multiple-dose vials into one syringe.
The product is AP-rated to Novartis Pharmaceuticals Corp.'s Sandostatin injection and is available in 1,000- and 5,000-microgram strengths in multiple-dose vials and in 50-, 100- and 500-microgram strengths in single-doze vials.
IV treprostinil is supplied in a multiple-dose vial that the patient may use for up to 30 days, accessed either by a single-use needle and syringe or via a vial adaptor that may remain in place for as long as the vial is in use.
Full browser ?